Sinovac Biotech Ltd (NASDAQ:SVA)

5.80
Delayed Data
As of May 22
 +0.06 / +1.05%
Today’s Change
4.51
Today|||52-Week Range
6.47
+10.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues56.8M49.2M72.5M63.1M
 
 
 
 
 
Cost of Goods Sold17.7M16.2M14.5M8.1M
 
 
 
 
 
Depreciation And Amortization4.8M4.5M6.7M8.4M
 
 
 
 
 
 
Operating ExpensesGross Income34.3M28.5M51.3M46.6M
 
 
 
 
 
General Expenses31.9M48.0M42.4M46.2M
 
 
 
 
 
Research And Development9.7M17.2M8.4M11.0M
 
 
 
 
 
Total Operating Expenses54.5M68.7M63.7M62.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income2.4M-19.5M8.8M458.0K
 
 
 
 
 
Extraordinary Charge-455.0K---57.0K0.00
 
 
 
Interest Expense On Debt980.4K2.2M3.1M3.5M
 
 
 
 
 
Other Expenses1.7M1.1M362.0K1.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income4.7M-19.6M8.1M1.1M
 
 
 
 
 
Income Taxes-5.1M-883.9K-2.2M-1.5M
 
 
 
 
 
Minority Interest-445.0K-3.9M-2.9M-515.0K
 
 
 
 
 
Net Income-844.7K-14.9M7.4M-851.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS54.6M54.9M55.3M55.7M
 
 
 
 
 
Shares To Calculate EPS Diluted54.6M54.9M55.8M55.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.27$0.13-$0.02
 
 
 
 
 
EPS Diluted-$0.02-$0.27$0.13-$0.02
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account